Loophole in Patent Law Brings ‘Miracle Drug’ to Patients Who Can’t Afford It

A generic version of a breakthrough cystic fibrosis drug, manufactured in Bangladesh for a fraction of the American price, may give some families around the world an unlikely lifeline.